Sernova Biotherapeutics Inc Share Price
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1400 CAD | 0.00% |
|
-6.67% | +7.69% |
| Market Cap | 5.29Cr 3.73Cr 3.27Cr 3.01Cr 2.82Cr 351.51Cr 5.4Cr 36Cr 14Cr 173.72Cr 14Cr 14Cr 602.4Cr | P/E 2026 * |
-4.67x | P/E 2027 * | -3.5x |
|---|---|---|---|---|---|
| Enterprise Value | 5.29Cr 3.73Cr 3.27Cr 3.01Cr 2.82Cr 351.51Cr 5.4Cr 36Cr 14Cr 173.72Cr 14Cr 14Cr 602.4Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.6x |
| Free-Float |
86.83% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 week | -6.67% | ||
| 1 month | -6.67% | ||
| 3 months | -15.15% | ||
| 6 months | +7.69% | ||
| Current year | +7.69% |
| 1 week | 0.12 |  | 0.16 |
| 1 month | 0.12 | | 0.17 |
| Current year | 0.12 | | 0.2 |
| 1 year | 0.12 | | 0.21 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
Steven Sangha
BRD | Director/Board Member | - | 24/04/2023 |
David Paterson
BRD | Director/Board Member | - | 01/09/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/05 | Option | Director | 2,60,000 | 0.0748% | ||
| 22/05 | Option | Director | 1,94,229 | 0.0559% | ||
| 22/05 | Option | Chairman | 3,60,000 | 0.1035% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -6.67% | -15.15% | -84.78% | 3.73Cr | |
| +5.25% | +8.09% | -14.78% | +12.08% | 13TCr | |
| -0.65% | +1.20% | +3.41% | -8.11% | 1.28TCr | |
| +1.30% | +10.51% | +42.91% | +109.94% | 847.83Cr | |
| -3.88% | -6.41% | -50.34% | -72.89% | 378.86Cr | |
| -0.38% | -0.97% | +17.98% | +37.20% | 251.54Cr | |
| -9.06% | +4.50% | +229.48% | +156.69% | 155.28Cr | |
| -8.75% | -13.25% | -26.46% | -23.39% | 153.09Cr | |
| -2.80% | -3.48% | -1.78% | -22.72% | 152.91Cr | |
| Average | -2.11% | -1.12% | +20.58% | +11.56% | 1.77TCr | |
| Weighted average by Cap. | +3.91% | +6.82% | -8.20% | +14.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 50L 35.24L 30.9L 28.48L 26.66L 33Cr 51.04L 3.42Cr 1.32Cr 16Cr 1.32Cr 1.29Cr 57Cr |
| Net income | -1.28Cr -90.4L -79.27L -73.07L -68.4L -85Cr -1.31Cr -8.78Cr -3.4Cr -42Cr -3.39Cr -3.32Cr -146.15Cr | -1.98Cr -1.39Cr -1.22Cr -1.13Cr -1.05Cr -131.46Cr -2.02Cr -14Cr -5.24Cr -65Cr -5.23Cr -5.12Cr -225.28Cr |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | CA$0.1400 | 0.00% | 2,13,550 |
| 25/26/25 | CA$0.1400 | 0.00% | 17,500 |
| 24/26/24 | CA$0.1400 | -3.45% | 2,08,654 |
| 23/26/23 | CA$0.1450 | -6.45% | 63,778 |
| 22/26/22 | CA$0.1550 | +3.33% | 78,770 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1400CAD
Average target price
0.4500CAD
Spread / Average Target
+221.43%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
